Immunitybio Eulerpool News

Immunitybio Aktie News

Immunitybio wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Immunitybio News stellen wir hier zusammen.

• 25. Juli ·

  Yahoo
  ImmunityBio, Inc. Announces Execution of $80 Million Equity Financing from Multiple Institutional Investors
• 25. Juli ·

  Yahoo
  ImmunityBio Reports 60% Increase in Revenue in Q2 2025, with Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code with Regulatory Updates
• 23. Juli ·

  Yahoo
  ImmunityBio’s (IBRX) ANKTIVA Gets Approved by UK’s Medicines and Healthcare Regulatory Agency
• 21. Juli ·

  SeekingAlpha
  ImmunityBio: Still Flashing Signs Of Life After Another Anktiva Approval
• 12. Juli ·

  SeekingAlpha
  ImmunityBio: High Stakes On Anktiva's Growth Amidst FDA Friction And Financial Pressures
• 9. Juli ·

  Yahoo
  Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
• 8. Juli ·

  Yahoo
  Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Amid Tariff Pause
• 8. Juli ·

  Yahoo
  UK MHRA Approves ImmunityBio’s ANKTIVA® Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
• 2. Juli ·

  Yahoo
  ImmunityBio (IBRX) Rated Buy After FDA Approvals and Pancreatic Cancer Trial Success
• 24. Juni ·

  Yahoo
  ImmunityBio (IBRX) Attains FDA’s Expanded Access Authorization for its Cancer BioShield Platform Anchored by ANKTIVA